Search results for: 'biopharmaceutical market growth'

03 Mar 2017  |  Global  |  Market Research

Global Biopharmaceutical Analytical Instrumentation Market, Forecast to 2022

Analytics Required for Biosimilar Drugs to Stimulate Market Growth

Infographics

×

The global biopharmaceutical analytical instrumentation market generated a revenue of $1,092 million in 2015 and is expected to grow at a compound annual growth rate (CAGR) of 7.2% from 2015 to 2022. The biosimilars segment, which is expected to reach $35 billion in 2025, will strongly drive the biopharmaceutical analytical instrumentation marke...

11 May 2015  |  Global  |  Market Research

Global Laboratory Analytical Instrumentation Market

Food Testing, Clinical Research, and Biopharmaceutical Industries will Fuel Market Growth

Infographics

×

The global laboratory analytical instrumentation market is driven by various industries including the food and beverage, environmental, biopharmaceuticals, clinical research, and diagnostics sectors. This study includes 3 segments based on analysis type such as separation, molecular, and elemental analyses. The geographical scope includes North Ame...

17 Oct 2019  |  Global  |  Market Research

Global Analytical Instrumentation Market in Pharmaceuticals, Biopharmaceuticals, and Nutraceuticals, Forecast to 2025

Growth of Biosimilars and Nutraceuticals will Drive Growth

Infographics

×

The global pharmaceuticals, biopharmaceuticals, and nutraceuticals market includes market revenues of analytical instrumentation applied in the 3 segments. Analytical instruments are applied in research, development, manufacturing, quality control, and distribution of drugs. Some key applications include (and are not limited to) drug discovery and ...

Frost & Sullivan presents post-COVID-19 growth opportunities and strategic imperatives for the global drug discovery and early development outsourcing market in this study, which covers research and development (R&D) efforts, market trends, key participants, drivers and restraints of market adoption, and recent mergers and acquisitions. The report ...

This Frost & Sullivan report analyzes the global pharmaceutical excipients market, with a focus on key regional markets, including North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa (MEA). The report provides both qualitative and quantitative analyses of various segments, including oral dosage excipients, injectable ...

The GCC has entered a period of strategic economic transformation as governments accelerate diversification efforts, strengthen economic resilience, and reduce dependence on hydrocarbon revenue amid heightened geopolitical uncertainty and evolving global trade dynamics. While the implications of the US-Iran conflict and periodic closures of the Str...

This strategic analysis service provides detailed analysis of world downstream processing markets. The service in powerpoint format (approximately 102 slides) focuses not just only on the revenues and competitor analysis but also on strategies for achieving success in this highly competitive market.

After two consecutive years of economic contraction in 2019 and 2020, Latin America achieved a ~7% real GDP growth in 2021. Some of the larger Latin American nations are emerging market growth leaders across the globe, and the region is known for its commodity exports, robust trade, and cost-effective labor. Amidst shifting socio-economic trends po...

Developed European nations have had a challenging socioeconomic environment in 2022, especially amidst highly volatile geopolitical tensions and record-high inflationary pressures. Economic growth is likely to remain subdued in 2023 across the whole region as high energy costs weigh on household spending and lower profit margins of businesses, give...